FUN FACT
-
Minneapolis has more golfers per capita than any city in the country.
C07: RLS Treatment Developments:
Expanded Medication Choices and Advances
in Treatment for Pregnancy and Pediatric RLS
Saturday, May 31, 2014
1:00pm – 5:00pm
Member Fee: $85
Nonmember Fee: $150
During this very practical course, attendees will review
the greatly expanded choices of treatment for RLS. Topics
include when and how to combine or switch from current
treatments to newer treatment options and advice on how
to switch or add new medication. This course will also
cover expanded treatment options and improved diagnosis
for three major RLS issues: pregnancy RLS; pediatric RLS;
and daytime, non-sensorimotor symptoms.
Chair:
Richard Allen, PhD
Faculty:
Mark Buchfuhrer, MD; Christopher Earley, PhD;
and Daniel Picchietti, MD
Psychologist Level of Content:
Intermediate
Target Audience:
Clinicians, including psychologists,
researchers and other health care providers
Learning Objectives:
1. Utilize the full expanded range of medications now
available for RLS treatment (opiates, alpha-2-delta
ligands, long-acting dopaminergics and IV iron);
2. Compare the choice of dopamine agonists treatment
to the knowledge about dopamine neurobiology,
augmentation and long-term use guidelines;
3. Identify and treat daytime and non-sensorimotor
symptoms of RLS;
4. Treat RLS during pregnancy applying new treatment
guidelines; and
5. Diagnose and treat pediatric RLS using new
diagnostic standards and evidence for treatment
choices.
C08: CPAP or Oral Appliance Therapy: Which
Treatment for Which Patient?
Saturday, May 31, 2014
1:00pm – 5:00pm
Member Fee: $85
Nonmember Fee: $150
This session will review recent studies evaluating the
effectiveness of CPAP and oral appliance therapy in long-
term treatment of OSA. Selection of patients for one or the
other therapy using clinical features and sleep tests will be
considered in the context of patient-centered management
of a chronic disease. Methods for tracking adherence to
therapy and the occurrence of adverse side effects will be
examined.
Chair:
David White, MD
Faculty:
Peter Cistulli, MD, PhD; Aarnoud Hoekema, MD,
DMD, PhD; Samuel Kuna, MD; and Clete Kushida, MD,
PhD, RST, RPSGT
Psychologist Level of Content:
Intermediate
Target Audience:
Clinicians, including psychologists,
dentists, researchers and other health care providers
interacting with patients with sleep apnea
Learning Objectives:
1. Describe how clinical information and sleep testing
promotes an integrated, patient-centered approach for
managing obstructive sleep apnea;
2. Evaluate the evidence comparing the relative
effectiveness of CPAP and oral appliance therapy;
3. Explain the need for and utility of clinical features and
sleep tests used in the selection of patients for CPAP
or oral appliance therapy; and
4. Review the modern methods for tracking and
enhancing compliance with therapy as well as
identifying adverse side effects.
Wednesday
June 4
Tuesday
June 3
Sunday
June 1
Monday
June 2
Saturday
May 31
16
